Exp Mol Med.  2013 Aug;45(8):e38.

Phospholipase D inhibitor enhances radiosensitivity of breast cancer cells

  • 1Department of Molecular Biology, College of Natural Science, Pusan National University, Busan, Republic of Korea. minds@pusan.ac.kr
  • 2Research Center, Dongnam Institute of Radiological and Medical Science, Busan, Republic of Korea. swanlakenz@yahoo.com
  • 3Translational Research Center for Protein Function Control and Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, Republic of Korea.


Radiation and drug resistance remain the major challenges and causes of mortality in the treatment of locally advanced, recurrent and metastatic breast cancer. Dysregulation of phospholipase D (PLD) has been found in several human cancers and is associated with resistance to anticancer drugs. In the present study, we evaluated the effects of PLD inhibition on cell survival, cell death and DNA damage after exposure to ionizing radiation (IR). Combined IR treatment and PLD inhibition led to an increase in the radiation-induced apoptosis of MDA-MB-231 metastatic breast cancer cells. The selective inhibition of PLD1 and PLD2 led to a significant decrease in the IR-induced colony formation of breast cancer cells. Moreover, PLD inhibition suppressed the radiation-induced activation of extracellular signal-regulated kinase and enhanced the radiation-stimulated phosphorylation of the mitogen-activated protein kinases p38 and c-Jun N-terminal kinase. Furthermore, PLD inhibition, in combination with radiation, was very effective at inducing DNA damage, when compared with radiation alone. Taken together, these results suggest that PLD may be a useful target molecule for the enhancement of the radiotherapy effect.


breast cancer; phospholipase D; phospholipase D inhibitor; radiosensitivity

MeSH Terms

Breast Neoplasms/*drug therapy/*enzymology/pathology
Cell Death/drug effects/radiation effects
Cell Line, Tumor
Cell Proliferation/drug effects/radiation effects
DNA Damage
Enzyme Activation/drug effects/radiation effects
Enzyme Inhibitors/*pharmacology/*therapeutic use
Extracellular Signal-Regulated MAP Kinases/metabolism
JNK Mitogen-Activated Protein Kinases/metabolism
Phospholipase D/*antagonists & inhibitors/metabolism
Radiation Tolerance/*drug effects
Radiation, Ionizing
p38 Mitogen-Activated Protein Kinases/metabolism
Enzyme Inhibitors
Extracellular Signal-Regulated MAP Kinases
JNK Mitogen-Activated Protein Kinases
p38 Mitogen-Activated Protein Kinases
Phospholipase D
Full Text Links
  • EMM
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr